Saturday 17 October 2026
Export POM’s income statement to Excel — free account
Pomdoctor Limited - Sponsored ADR
POM Healthcare Pharmaceutical Retailers
Pomdoctor Limited - Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $57.2 million, up 21.9% from fiscal 2024.
0.61
0.10
−14.08%
Follow POM
| Jun '26 | Dec '25 | Jun '25 | Dec '24 | |
|---|---|---|---|---|
Current Ratio |
0.35 | 0.48 | 0.17 | 0.21 |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 |
Debt/Assets |
587.82% | 420.32% | 1,030.00% | 947.59% |
Debt/Equity |
(0.88) | (0.94) | (0.19) | (0.19) |
Operating CF/Net income |
— | 0.00 | 0.00 | 0.00 |
Capex/Depreciation |
— | (6.73) | 0.00 | (0.25) |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
— | 0.00 | 0.00 | 0.00 |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow |
— | (21.38) | (2.09) | (2.21) |
Working Capital |
(20.22) | (16.19) | (22.97) | (19.41) |
Capital Expenditures |
— | (0.14) | 0.00 | 0.00 |
Net Current Asset Value |
(74.95) | (69.19) | (327.36) | (311.28) |
| Other line items | ||||
Quick Ratio |
0.32 | 0.44 | 0.13 | 0.15 |
Operating CF per Share |
— | 0.00 | 0.00 | 0.00 |
Capex per Share |
— | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 1 Oct 2026